Publications by authors named "Frank Mott"

Claim this Profile
F
First-In-Human Phase I Study of Tinengotinib (TT-00420), a Multiple Kinase Inhibitor, as a Single Agent in Patients With Advanced Solid Tumors.
Sarina A Piha-Paul, Binghe Xu, Ecaterina E Dumbrava, Siqing Fu, Daniel D Karp, Frank Mott

Oncologist· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perception of subjective lived experiences of individuals with anorexia-cachexia in patients with advanced lung cancer.
Sriram Yennurajalingam, Frank Mott, Zhanni Lu, Diana Urbauer, Penny Stanton

Asia Pac J Oncol Nurs· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, tolerability, and clinical activity of selinexor in combination with pembrolizumab in treatment of metastatic non-small cell lung cancer.
Mehmet Altan, Janet Tu, Denái R Milton, Bulent Yilmaz, Yanyan Tian, Frank E Mott

Cancer· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes of immunotherapy continued beyond radiographic disease progression in older adult patients with advanced non‑small cell lung cancer.
Eric K Singhi, Frank Mott, Michelle Worst, Cheuk Hong Leung, J Jack Lee

Oncol Lett· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Clinical Trial of Axitinib and Avelumab in Patients With Recurrent/Metastatic Adenoid Cystic Carcinoma.
Renata Ferrarotto, Luana G Sousa, Lei Feng, Frank Mott, George Blumenschein

J Clin Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sarcoidosis and Airway Disease After Immune Checkpoint Inhibitor Therapy: Case Study and Review of the Literature.
Felipe Soto, Luis F Torre-Sada, Frank E Mott, Sang T Kim, Roza Nurieva

J Immunother Precis Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of hearing loss and tinnitus symptoms with health-related quality of life among long-term oropharyngeal cancer survivors.
Puja Aggarwal, Marc-Elie Nader, Paul W Gidley, Raj Pratihar, Shirin Jivani, Frank E Mott

Cancer Med· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Effectiveness and Safety of Anti-PD-(L)1 Therapy Among Older Adults With Advanced Non-Small Cell Lung Cancer.
Mehmet Altan, Eric K Singhi, Michelle Worst, Brett W Carter, Cheuk H Leung, Frank E Mott

Clin Lung Cancer· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors associated with patient-reported fatigue among long-term oropharyngeal carcinoma survivors.
Puja Aggarwal, Katherine A Hutcheson, Ryan P Goepfert, Adam S Garden, Naveen Garg, Frank E Mott

Head Neck· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck.
Renata Ferrarotto, Moran Amit, Priyadharsini Nagarajan, M Laura Rubin, Ying Yuan, Frank E Mott

Clin Cancer Res· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic susceptibility to patient-reported xerostomia among long-term oropharyngeal cancer survivors.
Puja Aggarwal, Katherine A Hutcheson, Robert Yu, Jian Wang, Clifton D Fuller, Frank E Mott

Sci Rep· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poziotinib for Patients With Exon 20 Mutant Non-Small-Cell Lung Cancer: Results From a Phase II Trial.
Yasir Y Elamin, Jacqulyne P Robichaux, Brett W Carter, Mehmet Altan, Don L Gibbons, Frank E Mott

J Clin Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determinants of patient-reported xerostomia among long-term oropharyngeal cancer survivors.
Puja Aggarwal, Katherine A Hutcheson, Adam S Garden, Frank E Mott, Charles Lu

Cancer· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1/2a, open-label, multicenter study of RM-1929 photoimmunotherapy in patients with locoregional, recurrent head and neck squamous cell carcinoma.
David M Cognetti, Jennifer M Johnson, Joseph M Curry, Samith T Kochuparambil, Darren McDonald, Frank Mott

Head Neck· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Targeted Inhibitors in Metastatic Lung Squamous Cell Carcinoma With or Alterations.
Whitney E Lewis, Lingzhi Hong, Frank E Mott, George Simon, Carol C Wu

JTO Clin Res Rep· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of patients with oropharyngeal squamous cell carcinoma treated with induction chemotherapy followed by concurrent chemoradiation compared with those treated with concurrent chemoradiation.
Theresa W Guo, Faiez Saiyed, Christopher M K L Yao, Kimberley L Kiong, Julian Martinez, Frank E Mott

Cancer· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck.
Renata Ferrarotto, Moran Amit, Priyadharsini Nagarajan, M Laura Rubin, Ying Yuan, Frank E Mott

Clin Cancer Res· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Risk Factors With Patient-Reported Voice and Speech Symptoms Among Long-term Survivors of Oropharyngeal Cancer.
Puja Aggarwal, Katherine A Hutcheson, Adam S Garden, Frank E Mott, Ryan P Goepfert

JAMA Otolaryngol Head Neck Surg· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
End-of-life and goals of care discussions with cancer patients in the coronavirus pandemic.
Frank E Mott, Eduardo Bruera, Faye Johnson

Palliat Support Care· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytotoxic and targeted systemic therapy in patients with advanced cutaneous squamous cell carcinoma in the head and neck.
Samantha Tam, Mona Gajera, Xiaoning Luo, Bonnie S Glisson, Renata Ferrarotto, Frank E Mott

Head Neck· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Self-Reported Trismus: prevalence, severity and impact on quality of life in oropharyngeal cancer survivorship: a cross-sectional survey report from a comprehensive cancer center.
Richard C Cardoso, Mona Kamal, Jhankruti Zaveri, Mark S Chambers, G Brandon Gunn, Frank E Mott

Support Care Cancer· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial.
Tina Cascone, William N William, Annikka Weissferdt, Cheuk H Leung, Heather Y Lin, Frank E Mott

Nat Med· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes after salvage for HPV-positive recurrent oropharyngeal cancer treated with primary radiation.
Kaitlin M Christopherson, Amy C Moreno, Baher Elgohari, Neil Gross, Renata Ferrarotto, Frank E Mott

Oral Oncol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subjective functional outcomes in oropharyngeal cancer treated with induction chemotherapy using the MD Anderson Symptom Inventory (MDASI).
Frank E Mott, Ruth Sacks, Faye Johnson, Katherine A Hutcheson, Natalie Gallagher

Laryngoscope Investig Otolaryngol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Programmed Death-Ligand 1 Heterogeneity and Its Impact on Benefit From Immune Checkpoint Inhibitors in NSCLC.
Lingzhi Hong, Marcelo V Negrao, Seyedeh S Dibaj, Runzhe Chen, Alexandre Reuben, Frank E Mott

J Thorac Oncol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis